Drreddys Laboratories | RDY - Acreedores Comerciales





Acreedores Comerciales Cambio Fecha
ANI Pharmaceuticals USD 62.58M 7.21M 2025-12
Aurora Cannabis CAD 68.03M 18.68M 2025-12
Bayer EUR 7.08B 700M 2025-12
Canopy Growth CAD 19.96M 1.83M 2025-12
Cipla INR 30.35B 1.98B 2025-09
Corcept Therapeutics USD 40.44M 6M 2025-12
Drreddys Laboratories INR 454.04M 854K 2025-12
GlaxoSmithKline GBP 15.38B 294M 2025-12
Hikma Pharmaceutical USD 715M 104M 2025-12
Lonza CHF 471M 3M 2024-12
Novartis USD 4.46B 99M 2025-12
Pacira USD 15.15M 2.54M 2025-12
Phibro Animal Health USD 133.3M 2.7M 2025-12
Prestige Brands USD 42.95M 1.02M 2025-12
Richter Gedeon HUF 55.64B 11.84B 2025-12
Sun Pharmaceuticals INR 67.06B 5.21B 2025-09
Supernus Pharmaceuticals USD 107.8M 813K 2025-12
Teva Pharmaceutical Industries USD 2.53B 176M 2025-12